The role of the BRCA1 tumor suppressor in DNA double-strand break repair
- PMID: 16254187
- DOI: 10.1158/1541-7786.MCR-05-0192
The role of the BRCA1 tumor suppressor in DNA double-strand break repair
Abstract
The tumor suppressor gene BRCA1 was cloned in 1994 based on its linkage to early-onset breast and ovarian cancer. Although the BRCA1 protein has been implicated in multiple cellular functions, the precise mechanism that determines its tumor suppressor activity is not defined. Currently, the emerging picture is that BRCA1 plays an important role in maintaining genomic integrity by protecting cells from double-strand breaks (DSB) that arise during DNA replication or after DNA damage. The DSB repair pathways available in mammalian cells are homologous recombination and nonhomologous end-joining. BRCA1 function seems to be regulated by specific phosphorylations in response to DNA damage and we will focus this review on the roles played by BRCA1 in DNA repair and cell cycle checkpoints. Finally, we will explore the idea that tumor suppression by BRCA1 depends on its control of DNA DSB repair, resulting in the promotion of error-free and the inhibition of error-prone recombinational repair.
Similar articles
-
Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.Cancer Res. 2006 Feb 1;66(3):1401-8. doi: 10.1158/0008-5472.CAN-05-3278. Cancer Res. 2006. PMID: 16452195
-
BRCA1 requirement for the fidelity of plasmid DNA double-strand break repair in cultured breast epithelial cells.Environ Mol Mutagen. 2012 Jan;53(1):32-43. doi: 10.1002/em.21674. Epub 2011 Dec 15. Environ Mol Mutagen. 2012. PMID: 22170030
-
BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.Cancer Res. 2005 Dec 15;65(24):11384-91. doi: 10.1158/0008-5472.CAN-05-2156. Cancer Res. 2005. PMID: 16357146
-
BRCA1 gene in breast cancer.J Cell Physiol. 2003 Jul;196(1):19-41. doi: 10.1002/jcp.10257. J Cell Physiol. 2003. PMID: 12767038 Review.
-
BRCA1 regulation of transcription.Cancer Lett. 2006 May 18;236(2):175-85. doi: 10.1016/j.canlet.2005.04.037. Epub 2005 Jun 21. Cancer Lett. 2006. PMID: 15975711 Review.
Cited by
-
Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin.Cancer Res. 2010 Oct 15;70(20):7970-80. doi: 10.1158/0008-5472.CAN-09-4521. Epub 2010 Aug 26. Cancer Res. 2010. PMID: 20798217 Free PMC article.
-
Counting the cost of public and philanthropic R&D funding: the case of olaparib.J Pharm Policy Pract. 2022 Aug 16;15(1):47. doi: 10.1186/s40545-022-00445-9. J Pharm Policy Pract. 2022. PMID: 35974344 Free PMC article.
-
DCUN1D3, a novel UVC-responsive gene that is involved in cell cycle progression and cell growth.Cancer Sci. 2008 Nov;99(11):2128-35. doi: 10.1111/j.1349-7006.2008.00929.x. Epub 2008 Sep 22. Cancer Sci. 2008. PMID: 18823379 Free PMC article.
-
BRCA1 Mutation: A Predictive Marker for Radiation Therapy?Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):281-93. doi: 10.1016/j.ijrobp.2015.05.037. Int J Radiat Oncol Biol Phys. 2015. PMID: 26383678 Free PMC article. Review.
-
BRCA1 haploinsufficiency for replication stress suppression in primary cells.Nat Commun. 2014 Nov 17;5:5496. doi: 10.1038/ncomms6496. Nat Commun. 2014. PMID: 25400221 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous